NCT02051452View on ClinicalTrials.gov

Reversal of General Anesthesia With Methylphenidate

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Post Operative Cognitive DysfunctionEmergence From Anesthesia
Interventions
DRUG

Methylphenidate

OTHER

Saline

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02051452 - Reversal of General Anesthesia With Methylphenidate | Biotech Hunter | Biotech Hunter